Tri-Pharma

What Tri-Pharma does

Tri-Pharma is a privately held pharmaceutical wholesale distributor founded in 2009 by Todd Infante and headquartered in Kennesaw, Georgia. The company sources, procures, and delivers FDA-approved prescription medications, IV fluids, blood derivatives, OTC products, and medical supplies to healthcare providers across 44 states, Washington DC, and Puerto Rico. Its core positioning is the secondary pharmaceutical market — filling drug shortages and backorders that primary wholesalers cannot cover — with documented long-term relationships across hospitals, VA medical facilities, DOD facilities, oncology clinics, infusion centers, specialty pharmacies, surgery centers, and correctional facilities.

The company's technology backbone is the proprietary T3/EPCIS platform, a custom ERP system purpose-built for DSCSA compliance. It features direct AS2 connections to 13 third-party serialization providers (including Lspedia, Tracelink, TrackTraceRX, Inmar, and others), enabling sub-five-minute account setup for EPCIS data exchange, full lot/serial-level traceability, recall management workspace, and license validation. Tri-Pharma holds a GS1 Company Prefix (08600108006) and is fully licensed as a wholesale distributor across its covered jurisdictions.

Tri-Pharma operates a sales-led, relationship-driven go-to-market with dedicated account representatives assigned to enterprise healthcare buyers, supplemented by an inside sales team reachable via phone, email, and a website quote form. Pricing is quote-based and not publicly disclosed; payment terms are established via D&B credit checks for new accounts, with ACH, corporate check, and major credit cards accepted. The company does not distribute federal controlled substances and sources exclusively from FDA-approved manufacturers and state-licensed authorized trading partners.

Name

Tri-Pharma

Legal name

Tri-Pharma, Inc.

Website

https://tri-pharma.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Tri-Pharma is a privately held pharmaceutical wholesaler that sources FDA-approved medications and medical supplies, specializing in drug shortage and backorder fulfillment for hospitals, VA/DOD facilities, oncology clinics, and specialty pharmacies across 44 US states.

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Hospital & Health-System Pharmaceutical Distributors (HLAIAJAD), Third-Party Logistics (3PL) & Warehousing for Pharmaceuticals (HLAIAJAL)

Keywords

• Pharmaceutical wholesale
• Pharmaceutical distribution
• DSCSA compliance
• Drug shortage sourcing
• FDA-approved medications

Headquarters

HQ city

Kennesaw

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Wholesale Distribution: Revenue generated through the sale and distribution of FDA-approved prescription medications, OTC products, IV fluids, blood derivatives, and medical supplies to healthcare providers. Transaction-based pricing with established payment terms including ACH, corporate check, and major credit cards.
2. Specialty Pharmaceutical Sourcing: Specialized sourcing of hard-to-find and shortage-listed pharmaceuticals, providing margin opportunity through scarcity pricing during drug shortages.

Pricing tiers

Go-to-market motion3 records

Distribution channels2 records

Marketing channels6 records

Core offering

Tri-Pharma is a nationwide pharmaceutical wholesaler that sources, procures, and delivers FDA-approved prescription medications, IV fluids, blood derivatives, OTC products, and medical supplies to healthcare providers across the United States. The company specializes in secondary-market sourcing for hard-to-find and shortage-listed pharmaceuticals, supported by a proprietary T3/EPCIS platform for DSCSA-compliant serialization and traceability.

Product overview

Tri-Pharma is a nationwide pharmaceutical wholesaler offering a comprehensive product portfolio spanning five core pharmaceutical categories (Rx Pharmaceuticals, IV Fluids & Solutions, Blood Derivatives, Medical Supplies, and OTC products), complemented by the T3/EPCIS Platform—a proprietary compliance technology for DSCSA traceability. The T3 platform serves as the technological backbone enabling serialization, EPCIS data exchange, and regulatory compliance, while the pharmaceutical products represent the core distribution business.

Differentiator

Problem solved

Functional benefit

Products and services

• Rx Pharmaceuticals FDA-approved prescription medications with assigned National Drug Codes (NDCs), including generic alternatives and specialty pharmaceuticals. Distributed to hospitals, VA/DOD facilities, oncology clinics, infusion centers, specialty pharmacies, and surgery centers.
• IV Fluids & Solutions Intravenous fluids and solutions for medical facilities, shipped in specialized packaging with temperature monitoring to ensure product integrity.
• Blood Derivatives Blood-derived pharmaceutical products distributed to healthcare providers across the United States.
• Medical Supplies Healthcare medical supplies complementing pharmaceutical distribution for complete healthcare provider needs.
• OTC (Over-the-Counter) Over-the-counter medications available for distribution to healthcare providers.
• T3 / EPCIS Platform Proprietary DSCSA-compliant ERP system with AS2 Trading Partner Connections enabling precise tracking of pharmaceutical product movement. Features rapid account setup (under 5 minutes), serialization management, EPCIS capabilities, Transaction Data/Pedigree workspace, Recall Management Workspace, and customer/vendor license validation.

Quantifiable outcome

• 44 states and Washington DC served with pharmaceutical distribution
• +2 more outcomes

Named customers9 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration13 records

Feature6 records

Partnerships

15 partnerships are on record, tiered core.

• LspediacoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for secure real-time data exchange and DSCSA compliance.
• TracelinkcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for pharmaceutical traceability.
• TrackTraceRXcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for supply chain visibility.
• InmarcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system for DSCSA compliance.
• CerveycoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for pharmaceutical track and trace.
• ConsortiEXcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for healthcare supply chain compliance.
• MDScriptscoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection to Tri-Pharma's ERP system.
• MovilitascoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for pharmaceutical compliance.
• RfxcelcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for DSCSA compliance management.
• RXVirtualcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for pharmaceutical traceability.
• Gateway CheckercoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for EPCIS data exchange.
• InfinitrakcoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for supply chain visibility.
• RXScancoreTechnology or IntegrationThird-party serialization service provider with direct AS2 connection for pharmaceutical serialization.
• FDA-Approved ManufacturerscoreStrategic or Co-development PartnerAuthorized pharmaceutical manufacturers from which Tri-Pharma sources FDA-approved medications. All sourcing is from FDA-approved manufacturers and state-licensed authorized trading partners.
• State Licensed Authorized Trading PartnerscoreChannel Partner/ Reseller/ DistributorNetwork of authorized distributors, manufacturers, and dispensers verified as DSCSA-authorized trading partners for pharmaceutical distribution.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Broad incumbents

• McKesson: McKesson is one of the Big-3 U.S. pharmaceutical wholesalers and operates a large specialty distribution arm serving hospitals, oncology clinics, and federal facilities. Comparable as the dominant full-line incumbent against which Tri-Pharma positions its secondary-market, shortage-focused offering.
• Cencora (formerly AmerisourceBergen): Cencora is a top-tier pharmaceutical distributor with extensive specialty, community oncology, and federal customer reach. Highly comparable as an incumbent wholesaler whose primary relationships Tri-Pharma complements with secondary-market and shortage sourcing.
• Cardinal Health: Cardinal Health is the third Big-3 wholesaler and operates nuclear pharmacy, specialty, and at-Home Solutions distribution. Comparable as an incumbent with multi-channel pharmaceutical distribution to the same healthcare-provider end customers Tri-Pharma serves.

Emerging players

• RPh Innovations: Secondary-market pharmaceutical wholesaler focused on hard-to-find and shortage SKUs for hospitals and pharmacies. Comparable as a niche competitor in the same secondary/specialty distribution space where Tri-Pharma operates.

Direct peers

• Anda Inc (Teva): Anda is the U.S. distribution arm of Teva, focused on generic, specialty, and pharmaceutical supply to retail pharmacies and health systems. Comparable as a mid-to-large scale wholesaler with a generics/specialty mix overlapping Tri-Pharma's Rx distribution focus.
• H.D. Smith: H.D. Smith was a U.S. pharmaceutical wholesaler with strong specialty, generic, and home healthcare distribution before being acquired. Comparable as a specialty-focused wholesaler serving similar community pharmacy, hospital, and specialty provider segments.
• Smith Drug Company: Smith Drug Company is an independent U.S. wholesaler serving independent pharmacies, hospitals, and long-term care facilities. Comparable mid-sized peer distributing pharmaceuticals and related supplies to the same fragmented healthcare-provider base Tri-Pharma targets.
• Morris & Dickson: Morris & Dickson is a U.S. wholesale distributor focused on full-line and specialty pharmaceutical distribution to hospitals, health systems, and independent pharmacies. Highly comparable mid-sized peer with a similar mix of broad-line distribution and specialty/shortage sourcing into healthcare-provider customers.

Others

• LSPedia: LSPedia is a pharmaceutical serialization and DSCSA compliance platform provider. Comparable as an ecosystem partner and technology enabler—one of the 12+ AS2 connections Tri-Pharma's T3 platform integrates with for serialization data exchange.
• TraceLink: TraceLink is a leading pharmaceutical track-and-trace and supply-chain serialization network used across the industry. Comparable as a critical technology infrastructure provider that Tri-Pharma integrates with via direct AS2 connections to enable DSCSA-compliant trading-partner data exchange.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/tripharmainc
• Facebookfacebook.com/tripharmainc
• LinkedInlinkedin.com/company/tri-pharma-inc
• Instagraminstagram.com/tri_pharma_

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Tri-Pharma